We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Exploring Protein-protein Interactions Using Scaffolded and Assembled Peptides as Synthetic Binding Site Mimics

Video   Apr 24, 2015

 



About the Speaker
Upon her doctorate from Humboldt University in Berlin, Dr Eichler joined Torrey Pines Institute for Molecular Studies in San Diego, USA, first as a Postdoctoral Fellow, then as a Research Scientist, and finally as an Assistant Member. Back in Germany, she took up a position as a Group Leader at the Helmholtz Centre for Infection Research in Braunschweig, and in 2008 she was appointed Associate Professor of Medicinal Chemistry at the University of Erlangen-Nurnberg, Germany. Dr Eichler’s primary research interest is the exploration of protein-protein interactions using synthetic peptides.Abstract
The design and generation of peptides capable of mimicking the binding and/or functional sites of proteins, represents a promising strategy for the exploration and modulation of protein function through controlled interference with the underlying protein-ligand interactions.  We have recently designed a soluble synthetic peptide that functionally mimics the HIV-1 coreceptor CXCR4, which belongs to the family of seven-transmembrane GPCRs. This CXCR4 mimetic peptide, termed CX4-M1, presents the three extracellular loops (ECLs) of the receptor. In binding assays involving recombinant proteins, as well as in cellular infection assays, CX4-M1 was found to selectively recognize gp120 from HIV-1 strains that use CXCR4 for cellular entry (X4 tropic HIV-1). Furthermore, anti-HIV-1 antibodies modulate this interaction in a molecular mechanism related to that of their impact on the gp120-CXCR4 interaction. We could now show that the selectivity of CX4-M1 pertains not only to gp120 from X4 tropic HIV-1, but also to synthetic peptides presenting the V3 loops of these gp120 proteins. The V3 loop is thought to be an essential part of the coreceptor binding site of gp120 that contacts the second ECL of the coreceptor. We were able to experimentally confirm this notion in binding assays using substitution analogs of CX4-M1 and the V3 loop peptides, respectively, as well as in cellular infection assays.  These results demonstrate the feasibility of mimicking protein-protein interactions through peptide-peptide interactions, as well as the utility of these mimetic peptides to explore protein-protein interactions at the molecular level.

 
 
 
Advertisement
 

Recommended Videos

How To Achieve Compliance in QC of Nitrogen-containing Compounds

Video

Learn how to implement a fast and fully compliant SOP for testing of pharmaceuticals in your laboratory with our free webinar.

WATCH NOW

ADME 101 Drug Metabolism Webinar: Reaction Phenotyping Studies

Video

It is important to identify the enzymes that significantly contribute to the metabolism of a drug candidate and to evaluate the potential of a drug candidate to be a victim or perpetrator. Knowing how a drug candidate is eliminated by the human body is important in understanding the potential for drug-drug interactions.

WATCH NOW

COVID, One Year Later: What Do We Know Now?

Video

ACS Reactions catch up with experts they talked to at the start of the pandemic and ask, "what do we know now that we didn’t back then?"

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE